Background: Neuroblastoma (NB) is the most common tumour in children younger than 5 years old and notable for highly heterogeneous. Our aim was to quantify the intra-tumoural metabolic heterogeneity of primary tumour lesions by using F-FDG PET/CT and evaluate the prognostic value of intra-tumoural metabolic heterogeneity in NB patients.
Methods: We retrospectively enrolled 38 pretreatment NB patients in our study. F-FDG PET/CT images were reviewed and analyzed using 3D slicer software. The semi-quantitative metabolic parameters of primary tumour were measured, including the maximum standard uptake value (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG). The areas under the curve of cumulative SUV-volume histogram index (AUC-CSH index) was used to quantify intra-tumoural metabolic heterogeneity. The median follow-up was 21.3 months (range 3.6 - 33.4 months). The outcome endpoint was event-free survival (EFS), including progression-free survival and overall survival. Survival analysis was performed using Cox regression models and Kaplan Meier survival plots.
Results: In all 38 newly diagnosed NB patients, 2 patients died, and 17 patients experienced a relapse. The AUC-CSH (r=0.630, P<0.001) showed moderate correlation with the AUC-CSH. In univariate analysis, chromosome 11q deletion (P=0.033), Children's Oncology Group (COG) risk grouping (P=0.009), bone marrow involvement (BMI, P=0.015), and AUC-CSH (P=0.007) were associated with EFS. The AUC-CSH (P=0.036) and BMI (P=0.045) remained significant in multivariate analysis. The Kaplan Meier survival analyses demonstrated that patients with higher intra-tumoural metabolic heterogeneity and BMI had worse outcomes (log-rank P=0.002).
Conclusion: The intra-tumoural metabolic heterogeneity of primary lesions in NB was an independent prognostic factor for EFS. The combined predictive effect of intra-tumoural metabolic heterogeneity and BMI provided prognostic survival information in NB patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254530 | PMC |
| http://dx.doi.org/10.1186/s40644-022-00472-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer.
Biomolecules
December 2024
School of Cancer Sciences, Wolfson Wohl Cancer Research Institute, University of Glasgow, Estate, Glasgow G61 1BD, UK.
Colorectal cancer is the third most diagnosed malignancy worldwide and survival outcomes remain poor. Research is focused on the identification of novel prognostic and predictive biomarkers to improve clinical practice. There is robust evidence in the literature that inflammatory cytokine interleukin-6 (IL6) is elevated systemically in CRC patients and that this phenomenon is a predictor of poor survival outcome.
View Article and Find Full Text PDFExploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma.
Oral Oncol
November 2024
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom; Institute for Interdisciplinary Data Science and AI, University of Birmingham, Birmingham B15 2TT, United Kingdom. Electronic address:
Liquid biopsy profiling is gaining increasing promise towards biomarker-led identification and disease stratification of tumours, particularly for tumours displaying significant intra-tumoural heterogeneity (ITH). For head and neck squamous cell carcinoma (HNSCC), which display high levels of genetic ITH, identification of epigenetic modifications and methylation signatures has shown multiple uses in stratification of HNSCC for prognosis, treatment, and HPV status. In this study, we investigated the potential of liquid biopsy methylomics and genomic copy number to profile HNSCC.
View Article and Find Full Text PDFComparative morphology of tumour microenvironment in claudin-low and claudin-high breast cancers.
Pathol Res Pract
September 2024
Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:
Background: Claudin-low breast cancers (BCs) exhibit more aggressive behaviour compared to claudin-high types. Claudin-low BCs are often characterized by features such as a higher grade, enrichment of stemness characteristics, and a propensity for metastasis. Tumour microenvironment (TME) defined as the intricate network of surrounding cells, blood vessels, and extracellular matrix components influences the behaviour of cancer cells within the breast tissue.
View Article and Find Full Text PDFImproved tumour delivery of iron oxide nanoparticles for magnetic hyperthermia therapy of melanoma ultrasound guidance and In SPECT quantification.
Nanoscale
October 2024
Healthcare Biomagnetics Laboratory, University College London, 21 Albemarle Street, London, W1S 4BS, UK.
Magnetic field hyperthermia relies on the intra-tumoural delivery of magnetic nanoparticles by interstitial injection, followed by their heating on exposure to a remotely-applied alternating magnetic field (AMF). This offers a potential sole or adjuvant route to treating drug-resistant tumours for which no alternatives are currently available. However, two challenges in nanoparticle delivery currently hinder the effective clinical translation of this technology: obtaining enough magnetic material within the tumour to enable sufficient heating; and doing this accurately to limit or avoid damage to surrounding healthy tissue.
View Article and Find Full Text PDFRegulation of IFP in solid tumours through acoustic pressure to enhance infiltration of nanoparticles of various sizes.
J Drug Target
September 2024
Department of Ultrasound, School of Medicine, The Second Affiliated Hospital, South China University of Technology, Guangzhou, China.
Article Synopsis
- Recent advancements in nanomedicine have led to the creation of nanoparticles that can target tumors effectively due to the enhanced permeability and retention (EPR) effect, although high interstitial fluid pressure (IFP) in solid tumors poses a challenge for effective delivery.
- This study explored the use of low-frequency non-focused ultrasound (LFNFU) combined with ultrasonic targeted microbubble destruction (UTMD) to reduce IFP and improve the accumulation of different sized Cy5.5-conjugated mesoporous silica nanoparticles (Cy5.5-MSNs) in tumors.
- Results showed that UTMD significantly increased the delivery of Cy5.5-MSNs, achieving a sevenfold higher accumulation at an optimal acoustic pressure of
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!